Literature DB >> 7507230

The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.

A Seth1, L Robinson, A Panayiotakis, D M Thompson, D R Hodge, X K Zhang, D K Watson, K Ozato, T S Papas.   

Abstract

EndoA is a type II keratin and with EndoB (type I keratin), constitutes intermediate filaments in various simple epithelial tissues. EndoA is developmentally regulated and has an enhancer that is located at the 3'- end of the gene. This enhancer contains two single and five dual Ets binding sites. Thus far, no other promoter or enhancer has been shown to contain as many potential clustered Ets binding sites. To study the transcriptional regulation of EndoA by the ETS family proteins, we amplified the EndoA enhancer fragment from mouse genomic DNA by PCR, and cloned it into the pBLCAT2 vector upstream from the CAT reporter gene. Several pBLCAT-ENDOA clones were sequenced to verify the presence of all the ETS binding sites. Clones that did not show any point mutations in the ETS binding sites were chosen to study the transcription regulation by ETS1, ETS2 and ERGB/FLI-1 gene products. EMSA results indicated that the ETS1, ETS2 and ERGB/FLI-1 proteins bind to the enhancer sequence, and DNase I protection data demonstrated that the ETS proteins protect all seven EBS core sequences. Cotransfection of the COS cells with the pBLCAT-ENDOA construct, along with increasing amounts of different ETS expression vectors, resulted in a significant induction of CAT reporter gene expression. Previously, we have shown that the overexpression of the ETS1 gene transforms NIH3T3, and these transformed cells (7AQS2.1) produce high levels of ETS1 protein (Seth & Papas, 1990). In this report, we show that the undifferentiated P19 EC cells do not express detectable levels of ETS1; however, an elevated level of ETS1 is expressed in differentiated derivatives of these cells. We therefore used these two cell lines to examine the activity of the EndoA enhancer with the ETS1 product. Transfection of the pBLCAT-ENDOA construct alone in undifferentiated P19 EC cells results in very low CAT gene expression; however, upon differentiation with retinoic acid the level of CAT gene activity increases dramatically. Similarly, an increase in CAT expression from the same construct (pBLCAT-ENDOA) was also observed in 7AQS2.1 cells. Our results therefore indicate that the EndoA enhancer is regulated by ETS proteins via interaction with multiple ETS-binding site sequences.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507230

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy.

Authors:  J A Iñiguez-Lluhí; D Pearce
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques.

Authors:  L Robinson; A Panayiotakis; T S Papas; I Kola; A Seth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Intermediate filaments: a historical perspective.

Authors:  Robert G Oshima
Journal:  Exp Cell Res       Date:  2007-04-11       Impact factor: 3.905

4.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.

Authors:  P Oettgen; R M Alani; M A Barcinski; L Brown; Y Akbarali; J Boltax; C Kunsch; K Munger; T A Libermann
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  ETS1 suppresses tumorigenicity of human colon cancer cells.

Authors:  H Suzuki; V Romano-Spica; T S Papas; N K Bhat
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.

Authors:  D D Spyropoulos; P N Pharr; K R Lavenburg; P Jackers; T S Papas; M Ogawa; D K Watson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice.

Authors:  Hiroshi Kawada; Tatsuya Ito; Pamela N Pharr; Demetri D Spyropoulos; Dennis K Watson; Makio Ogawa
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

9.  Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.

Authors:  B S Braun; R Frieden; S L Lessnick; W A May; C T Denny
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.